Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vs intravenous iron for iron deficiency in fertility treatment
2020-000201-84Phase 4Completed
- Sponsor
- Das Kinderwunsch Institut Schenk GmbH
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ferric carboxymaltose and ferrous fumarate + ascorbic acid in iron deficiency anemia (IDA) (2 arms), sponsored by Das Kinderwunsch Institut Schenk GmbH. Primary endpoint: Hemoglobin concentration at 4 weeks. Started Jan 2020; status: completed.
02
Drugs
ferric carboxymaltoseferrous fumarate + ascorbic acid
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2020-000201-84.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000201-84.